Influenza and RSV increase the demand for antibiotics and antiviral drugs

Influenza and RSV increase the demand for antibiotics and antiviral drugs

Influenza and RSV increase the demand for antibiotics and antiviral drugs

While the shortage of amoxicillin, especially its liquid and chewable forms, has proven frustrating for pharmacists, doctors and parents whose children have grown accustomed to the drug’s bubblegum and strawberry-flavored variants, experts say there’s no need to panic: Stocks of effective alternatives like cephalexin and clindamycin remain abundant, according to the FDA

But the process of finding a suitable alternative delays care and can be frustrating. “It’s already stressful to take care of a sick child, and now you also have to find a prescription. But there are alternatives that are suitable for age and indications,” said dr. Michael Ganio, senior director of pharmacy practice and quality at the American Society of Health-System Pharmacists.

While hundreds of drugs, including chemotherapy and anesthetics, have been in short supply for years, the current shortage of amoxicillin and antiviral drugs is unusual, said Dr. Moved. He attributed the surge in demand to an early rise in respiratory illnesses this year.

“These are not typical drug shortages, which are related to production or supply chain disruptions,” he said. While most drugmakers prepare for seasonal variations, he said, “We don’t use a lot of Tamiflu in the Northern Hemisphere in the summer, and manufacturers plan accordingly. This hit earlier than expected.”

FDA, which monitors drug shortages your website, said there is no national shortage of Tamiflu, but that some regions of the country are experiencing temporary shortages. There are numerous alternatives to Tamiflu that can prevent the flu and reduce the severity and duration of the illness, but many doctors are not familiar with these options, experts say.

The shortages highlight the fragility of the nation’s drug supply chain, especially for cheap generic drugs like amoxicillin that are made by only a few companies. Experts say the low prices of such drugs discourage investment in sophisticated quality management systems, which can improve manufacturers’ agility in shortages and allow them to ramp up production more quickly.

One producer, Sandoz, said it was ramping up production to meet increased demand and hoped to double its production in the coming months. “We are facing challenges to meet this sudden spike in demand now that flu season is in full swing,” the company said in a statement.

#Influenza #RSV #increase #demand #antibiotics #antiviral #drugs

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button